212 related articles for article (PubMed ID: 33146828)
1. IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
Di Napoli A; Greco D; Scafetta G; Ascenzi F; Gulino A; Aurisicchio L; Santanelli Di Pompeo F; Bonifacino A; Giarnieri E; Morgan J; Mancini R; Kadin ME
Cancer Immunol Immunother; 2021 May; 70(5):1379-1392. PubMed ID: 33146828
[TBL] [Abstract][Full Text] [Related]
2. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
Di Napoli A; Pepe G; Giarnieri E; Cippitelli C; Bonifacino A; Mattei M; Martelli M; Falasca C; Cox MC; Santino I; Giovagnoli MR
PLoS One; 2017; 12(7):e0181097. PubMed ID: 28715445
[TBL] [Abstract][Full Text] [Related]
3. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.
Kadin ME; Morgan J; Kouttab N; Xu H; Adams WP; Glicksman C; McGuire P; Sieber D; Epstein AL; Miranda RN; Clemens MW
Aesthet Surg J; 2020 May; 40(6):630-637. PubMed ID: 31589747
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas.
Hu H; Shklovskaya E; Deva A; Xu H; Fan K; Brosamer K; Willson R; Khan I; Sinha M; Kadin ME
Am J Hematol; 2023 Nov; 98(11):E312-E314. PubMed ID: 37646570
[TBL] [Abstract][Full Text] [Related]
6. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
8. Achieving Reliable Diagnosis in Late Breast Implant Seromas: From Reactive to Anaplastic Large Cell Lymphoma.
Di Napoli A
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):15S-22S. PubMed ID: 30817552
[TBL] [Abstract][Full Text] [Related]
9. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
[TBL] [Abstract][Full Text] [Related]
10. CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.
Zeyl VG; Xu H; Khan I; Machan JT; Clemens MW; Hu H; Deva A; Glicksman C; McGuire P; Adams WP; Sieber D; Sinha M; Kadin ME
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958303
[TBL] [Abstract][Full Text] [Related]
11. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Kadin ME
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
[TBL] [Abstract][Full Text] [Related]
12. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants.
Locke MB; Lofts J
ANZ J Surg; 2017 Oct; 87(10):789-794. PubMed ID: 25827224
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large-cell lymphoma associated with breast implants: a unique entity within the spectrum of peri-implant effusions.
Chai SM; Kavangh S; Ooi SS; Sterrett GF; Cull G; Plunkett M; Spagnolo D; Amanuel B; Joske D; Leslie C; Barham T; Frost F
Diagn Cytopathol; 2014 Nov; 42(11):929-38. PubMed ID: 24687769
[TBL] [Abstract][Full Text] [Related]
14. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
15. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Xu H; Glicksman CA
Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
[TBL] [Abstract][Full Text] [Related]
16. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Morgan J; Wei W; Song Z; Yang Y
Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
[TBL] [Abstract][Full Text] [Related]
17. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
18. Risk of Anaplastic Large-Cell Lymphoma (ALCL) in Cases of Late Seroma Formation After Breast Implant Insertion.
Hwang K; Kim H; Kim HM; Kim JH
Eplasty; 2021; 21():e4. PubMed ID: 33747338
[No Abstract] [Full Text] [Related]
19. New insights into breast implant-associated anaplastic large cell lymphoma.
Laurent C; Haioun C; Brousset P; Gaulard P
Curr Opin Oncol; 2018 Sep; 30(5):292-300. PubMed ID: 30096095
[TBL] [Abstract][Full Text] [Related]
20. IL-9 is a Biomarker of BIA-ALCL Detected Rapidly By Lateral Flow Assay.
Xu P; Kourentzi K; Willson R; Hu H; Deva A; McGuire P; Glicksman C; Kadin M
Aesthet Surg J; 2024 Jun; ():. PubMed ID: 38913383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
